Curaleaf Holdings reacted to the House Committee on Agriculture's approval of an amendment to the 2018 Farm Bill. As a large operator in the cannabis sector and as a company that recently announced its entry into the hemp-derived THC products space, Curaleaf issued a statement to clarify its position regarding yesterday's Miller amendment.
"We disagree with yesterday's amendment filed by Mary Miller (R-IL), which is an attempt to roll back the Farm Bill," shared Executive Chairman Boris Jordan. "We support hemp farmers, and we believe that hemp-derived products made within the guidelines of the Farm Bill should be available to adults with strict age gating and safety standards. We believe there should be one regulatory framework for all cannabinoids, and that all legal players in the hemp-derived product market must adhere to the same safety and age-restrictive standards in order to combat the dangers of the illicit market – just as in cannabis."
For more information:
Curaleaf
[email protected]
curaleaf.com